Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum

We tested human sera from large, demographically balanced cohorts of BNT162b2 vaccine recipients (n=51) and COVID-19 patients (n=44) for neutralizing antibodies against SARS-CoV-2 variants B.1.1.7 and B.1.351. Although the effect is more pronounced in the vaccine cohort, both B.1.1.7 and B.1.351 sho...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:medRxiv
Autors principals: Bates, Timothy A., Leier, Hans C., Lyski, Zoe L., McBride, Savannah K., Coulter, Felicity J., Weinstein, Jules B., Goodman, James R., Lu, Zhengchun, Siegel, Sarah A. R., Sullivan, Peter, Strnad, Matt, Brunton, Amanda E., Lee, David X., Curlin, Marcel E., Messer, William B., Tafesse, Fikadu G.
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8043482/
https://ncbi.nlm.nih.gov/pubmed/33851185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.04.04.21254881
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars